老年人血脂异常管理中国专家共识  

Chinese expert consensus on management of dyslipidemia in the elderly

作　　者：刘梅林[1] 张雨濛 付志方[1] 叶平[2] 郭艺芳[3] 汪芳[4] 何青[4] 李建军[5] 严晓伟[6] 廖玉华[7] 周晓芳[8] 拓西平[9] 王朝晖[10] 老年人血脂异常管理中国专家共识组 Liu Meilin;Zhang Yumeng;Fu Zhifang;Ye Ping;Guo Yifang;Wang Fang;He Qing;Li Jianjun;Yan Xiaowei;Liao Yuhua;Zhou Xiaofang;Tuo Xiping;Wang Zhaohui;Chinese Expert Consensus Group on Management of Dyslipidemia in the Elderly(Department of Geriatrics,Peking University First Hospital,Beijing 100034,China;Department of Cardiology,Second Medical Center,PLA General Hospital,Beijing 100853,China;Department of Geriatric Cardiology,Hebei General Hospital,Shijiazhuang 050051,China;Department of Cardiology,Beijing Hospital,Beijing 100005,China;Fuwai Hospital,National Center for Cardiovascular Diseases,Peking Union Medical College,Chinese Academy of Medical Sciences,Beijing 100037,China;Department of Cardiology,Peking Union Medical College Hospital,Peking Union Medical College,Chinese Academy of Medical Sciences,Beijing 100730,China;Department of Cardiology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Geriatrics,Sichuan Provincial People′s Hospital,Chengdu 610072,China;Department of Geriatrics,Changhai Hospital,Shanghai 200433,China;Department of Geriatrics,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;不详)

机构地区：[1]北京大学第一医院老年病内科,北京100034 [2]解放军总医院第二医学中心老年心血管科,北京100853 [3]河北省人民医院老年心血管内科,石家庄050057 [4]北京医院心内科,北京100005 [5]中国医学科学院,北京协和医学院,阜外医院,国家心血管病中心,北京100037 [6]中国医学科学院,北京协和医学院,北京协和医院心内科,北京100730 [7]华中科技大学同济医学院附属协和医院心内科,武汉430022 [8]四川省人民医院老年科,成都610072 [9]上海长海医院老年病科,上海200433 [10]华中科技大学同济医学院附属协和医院老年科,武汉430022 [11]不详

出　　处：《中华内科杂志》2022年第10期1095-1118,共24页Chinese Journal of Internal Medicine

摘　　要：血脂异常是导致动脉粥样硬化性心血管疾病(ASCVD)的重要危险因素,他汀类药物延缓ASCVD的发生、发展并降低心血管事件及死亡的风险。由于对安全性的担忧,老年人调脂药物使用不足、停药率高。本专家共识依据老年人使用调脂药物的临床证据,参考国内外血脂管理指南及专家共识推荐,对我国老年人的血脂异常提出管理建议,旨在促进我国老年ASCVD防治工作。Dyslipidemia is an important risk factor of atherosclerotic cardiovascular disease(ASCVD).Statins delay the occurrence and development of ASCVD,and reduce the risk of cardiovascular events and death.Due to safety concerns,there exist insufficient use of lipid-lowering agents and a high withdrawal rate of the agents in the elderly.To promote the prevention and treatment of ASCVD,this expert consensus is issued and focuses on the management of dyslipidemia of Chinese elderly basing on the clinical evidence of the use of lipid-lowering drugs by the elderly,and the lipid management guidelines and expert consensus recommendations at home and abroad.

关 键 词：老年人 血脂异常 他汀类 动脉粥样硬化 

分 类 号：R589.2[医药卫生—内分泌]